WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-1.08%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$8.53B
AUM Growth
+$112M
(+1.3%)
Cap. Flow
+$339M
Cap. Flow
% of AUM
3.98%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
809
New
193
Increased
196
Reduced
149
Closed
229
Top Buys
| 1 |
Analog Devices
ADI
|
$178M |
| 2 |
AbbVie
ABBV
|
$123M |
| 3 |
Electronic Arts
EA
|
$107M |
| 4 |
Autodesk
ADSK
|
$95.8M |
| 5 |
Keysight
KEYS
|
$82.3M |
Top Sells
| 1 |
HES
Hess
HES
|
$125M |
| 2 |
Amphenol
APH
|
$111M |
| 3 |
Cencora
COR
|
$106M |
| 4 |
Microsoft
MSFT
|
$99.2M |
| 5 |
Neurocrine Biosciences
NBIX
|
$95.5M |
Sector Composition
| 1 | Healthcare | 38.53% |
| 2 | Technology | 26.19% |
| 3 | Industrials | 9.44% |
| 4 | Energy | 7.95% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Tyra Biosciences
TYRA
$674M
| $5.65M | 0.07% |
410,435
| – | – |
|
302
lululemon athletica
LULU
$19.9B
| $5.53M | 0.06% |
14,348
+10,516
| +274% | +$4.06M |
|
303
Enliven Therapeutics
ELVN
$1.19B
| $5.41M | 0.06% |
+395,686
| New | +$5.41M |
|
304
Bausch + Lomb
BLCO
$5.31B
| $5.25M | 0.06% |
309,491
-523,019
| -63% | -$8.87M |
|
305
Coty
COTY
$3.81B
| $5.21M | 0.06% |
+474,668
| New | +$5.21M |
|
|
MRNS
306
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $5.08M | 0.06% |
631,520
-168,480
| -21% | -$1.36M |
|
307
Replimune Group
REPL
$494M
| $5.02M | 0.06% |
293,622
+18,621
| +7% | +$319K |
|
|
RYZB
308
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $5M | 0.06% |
+225,000
| New | +$5M |
|
|
FNA
309
DELISTED
Paragon 28, Inc.
FNA
| $4.92M | 0.06% |
392,264
+198,283
| +102% | +$2.49M |
|
310
Xenon Pharmaceuticals
XENE
$3.02B
| $4.9M | 0.06% |
143,451
-146,949
| -51% | -$5.02M |
|
|
SABA
311
Saba Capital Income & Opportunities Fund II
SABA
$257M
| $4.8M | 0.06% |
621,739
+584,431
| +1,567% | +$4.51M |
|
312
Woodward
WWD
$14.6B
| $4.77M | 0.06% |
38,413
-11,984
| -24% | -$1.49M |
|
313
Corning
GLW
$61B
| $4.76M | 0.06% |
+156,218
| New | +$4.76M |
|
314
Tenet Healthcare
THC
$17.3B
| $4.73M | 0.06% |
+71,830
| New | +$4.73M |
|
315
Biomea Fusion
BMEA
$114M
| $4.7M | 0.06% |
341,673
| – | – |
|
316
ODP
ODP
$668M
| $4.69M | 0.06% |
101,681
+23,241
| +30% | +$1.07M |
|
|
FDEU
317
DELISTED
First Trust Dynamic Europe Equity Income Fund
FDEU
| $4.65M | 0.05% |
374,816
| – | – |
|
318
Sweetgreen
SG
$1.06B
| $4.62M | 0.05% |
392,960
+150,080
| +62% | +$1.76M |
|
319
Pegasystems
PEGA
$9.5B
| $4.56M | 0.05% |
+210,232
| New | +$4.56M |
|
320
CRISPR Therapeutics
CRSP
$4.99B
| $4.56M | 0.05% |
100,412
+50,412
| +101% | +$2.29M |
|
321
Levi Strauss
LEVI
$8.79B
| $4.55M | 0.05% |
335,302
+212,282
| +173% | +$2.88M |
|
322
ManpowerGroup
MAN
$1.91B
| $4.51M | 0.05% |
61,521
+37,736
| +159% | +$2.77M |
|
323
PROS Holdings
PRO
$746M
| $4.51M | 0.05% |
130,165
-36,727
| -22% | -$1.27M |
|
324
Crinetics Pharmaceuticals
CRNX
$3.35B
| $4.46M | 0.05% |
+150,000
| New | +$4.46M |
|
|
KLRS
325
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $4.44M | 0.05% |
89,855
+14,724
| +20% | +$728K |
|